JP2009100687A - ｍｉｃｒｏＲＮＡ発現プロファイリングに基づく膀胱癌の検出方法 - Google Patents
ｍｉｃｒｏＲＮＡ発現プロファイリングに基づく膀胱癌の検出方法 Download PDFInfo
- Publication number
- JP2009100687A JP2009100687A JP2007276191A JP2007276191A JP2009100687A JP 2009100687 A JP2009100687 A JP 2009100687A JP 2007276191 A JP2007276191 A JP 2007276191A JP 2007276191 A JP2007276191 A JP 2007276191A JP 2009100687 A JP2009100687 A JP 2009100687A
- Authority
- JP
- Japan
- Prior art keywords
- mir
- mirna
- expression level
- bladder cancer
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000002679 microRNA Substances 0.000 title claims abstract description 96
- 206010005003 Bladder cancer Diseases 0.000 title claims abstract description 43
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 title claims abstract description 43
- 201000005112 urinary bladder cancer Diseases 0.000 title claims abstract description 43
- 238000000034 method Methods 0.000 title claims abstract description 37
- 108700011259 MicroRNAs Proteins 0.000 title description 52
- 238000010195 expression analysis Methods 0.000 title description 2
- 230000014509 gene expression Effects 0.000 claims abstract description 66
- 108091070501 miRNA Proteins 0.000 claims abstract description 51
- 108091025686 miR-199a stem-loop Proteins 0.000 claims abstract description 18
- 108091028684 Mir-145 Proteins 0.000 claims abstract description 15
- 108091079016 miR-133b Proteins 0.000 claims abstract description 15
- 108091043162 miR-133b stem-loop Proteins 0.000 claims abstract description 15
- -1 miR-195 Proteins 0.000 claims abstract description 15
- 108091043187 miR-30a stem-loop Proteins 0.000 claims abstract description 11
- 108091029750 miR-30a-1 stem-loop Proteins 0.000 claims abstract description 11
- 108091030035 miR-30a-2 stem-loop Proteins 0.000 claims abstract description 11
- 108091027559 Mir-96 microRNA Proteins 0.000 claims abstract description 10
- 108091079012 miR-133a Proteins 0.000 claims abstract description 10
- 108091024038 miR-133a stem-loop Proteins 0.000 claims abstract description 10
- 108091060382 miR-140 stem-loop Proteins 0.000 claims abstract description 10
- 108091029500 miR-183 stem-loop Proteins 0.000 claims abstract description 10
- 108091086713 miR-96 stem-loop Proteins 0.000 claims abstract description 10
- 108091070961 miR-96-3 stem-loop Proteins 0.000 claims abstract description 10
- 108091007773 MIR100 Proteins 0.000 claims abstract description 9
- 108091046841 MiR-150 Proteins 0.000 claims abstract description 9
- 108091028695 MiR-224 Proteins 0.000 claims abstract description 9
- 108091080933 Mir-192/215 microRNA precursor Proteins 0.000 claims abstract description 9
- 108091061943 Mir-218 microRNA precursor family Proteins 0.000 claims abstract description 9
- 108091062140 Mir-223 Proteins 0.000 claims abstract description 9
- 108091060302 Mir-320 Proteins 0.000 claims abstract description 9
- 108091080995 Mir-9/mir-79 microRNA precursor family Proteins 0.000 claims abstract description 9
- 108091064157 miR-106a stem-loop Proteins 0.000 claims abstract description 9
- 108091024609 miR-124b stem-loop Proteins 0.000 claims abstract description 9
- 108091081188 miR-124b-1 stem-loop Proteins 0.000 claims abstract description 9
- 108091060300 miR-124b-2 stem-loop Proteins 0.000 claims abstract description 9
- 108091091360 miR-125b stem-loop Proteins 0.000 claims abstract description 9
- 108091028466 miR-130b stem-loop Proteins 0.000 claims abstract description 9
- 108091029379 miR-139 stem-loop Proteins 0.000 claims abstract description 9
- 108091072763 miR-151 stem-loop Proteins 0.000 claims abstract description 9
- 108091037426 miR-152 stem-loop Proteins 0.000 claims abstract description 9
- 108091081505 miR-190 stem-loop Proteins 0.000 claims abstract description 9
- 108091086834 miR-190-2 stem-loop Proteins 0.000 claims abstract description 9
- 108091088730 miR-215 stem-loop Proteins 0.000 claims abstract description 9
- 108091040176 miR-218 stem-loop Proteins 0.000 claims abstract description 9
- 108091047084 miR-9 stem-loop Proteins 0.000 claims abstract description 9
- 230000008859 change Effects 0.000 claims abstract description 5
- 206010028980 Neoplasm Diseases 0.000 claims description 26
- 239000000126 substance Substances 0.000 claims description 22
- 201000011510 cancer Diseases 0.000 claims description 20
- 238000012216 screening Methods 0.000 claims description 19
- 230000007423 decrease Effects 0.000 claims description 11
- 238000001514 detection method Methods 0.000 claims description 7
- 238000003753 real-time PCR Methods 0.000 claims description 6
- 238000012360 testing method Methods 0.000 claims description 5
- 238000012258 culturing Methods 0.000 claims description 4
- 230000002265 prevention Effects 0.000 claims description 4
- 210000004027 cell Anatomy 0.000 description 23
- 108090000623 proteins and genes Proteins 0.000 description 14
- 238000004458 analytical method Methods 0.000 description 8
- 208000020816 lung neoplasm Diseases 0.000 description 5
- 239000000523 sample Substances 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- 206010009944 Colon cancer Diseases 0.000 description 4
- 108700020796 Oncogene Proteins 0.000 description 4
- 230000003247 decreasing effect Effects 0.000 description 4
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 3
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 3
- 101001120822 Homo sapiens Putative microRNA 17 host gene protein Proteins 0.000 description 3
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 3
- 102100026055 Putative microRNA 17 host gene protein Human genes 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 201000005202 lung cancer Diseases 0.000 description 3
- 238000012552 review Methods 0.000 description 3
- 208000010839 B-cell chronic lymphocytic leukemia Diseases 0.000 description 2
- 206010006187 Breast cancer Diseases 0.000 description 2
- 208000026310 Breast neoplasm Diseases 0.000 description 2
- 101001018145 Homo sapiens Mitogen-activated protein kinase kinase kinase 3 Proteins 0.000 description 2
- 208000031422 Lymphocytic Chronic B-Cell Leukemia Diseases 0.000 description 2
- 108091030146 MiRBase Proteins 0.000 description 2
- 102100033059 Mitogen-activated protein kinase kinase kinase 3 Human genes 0.000 description 2
- 108700019961 Neoplasm Genes Proteins 0.000 description 2
- 102000048850 Neoplasm Genes Human genes 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 108010051489 calin Proteins 0.000 description 2
- 230000004663 cell proliferation Effects 0.000 description 2
- 210000000349 chromosome Anatomy 0.000 description 2
- 208000032852 chronic lymphocytic leukemia Diseases 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 108020004999 messenger RNA Proteins 0.000 description 2
- 108091057645 miR-15 stem-loop Proteins 0.000 description 2
- 108091027943 miR-16 stem-loop Proteins 0.000 description 2
- 238000002493 microarray Methods 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- 238000003757 reverse transcription PCR Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- MEOVPKDOYAIVHZ-UHFFFAOYSA-N 2-chloro-1-(1-methylpyrrol-2-yl)ethanol Chemical compound CN1C=CC=C1C(O)CCl MEOVPKDOYAIVHZ-UHFFFAOYSA-N 0.000 description 1
- WQZIDRAQTRIQDX-UHFFFAOYSA-N 6-carboxy-x-rhodamine Chemical compound OC(=O)C1=CC=C(C([O-])=O)C=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 WQZIDRAQTRIQDX-UHFFFAOYSA-N 0.000 description 1
- BZTDTCNHAFUJOG-UHFFFAOYSA-N 6-carboxyfluorescein Chemical compound C12=CC=C(O)C=C2OC2=CC(O)=CC=C2C11OC(=O)C2=CC=C(C(=O)O)C=C21 BZTDTCNHAFUJOG-UHFFFAOYSA-N 0.000 description 1
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- 244000304337 Cuminum cyminum Species 0.000 description 1
- 108010058544 Cyclin D2 Proteins 0.000 description 1
- 102000006312 Cyclin D2 Human genes 0.000 description 1
- 238000000018 DNA microarray Methods 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102100034343 Integrase Human genes 0.000 description 1
- 102000043136 MAP kinase family Human genes 0.000 description 1
- 108091054455 MAP kinase family Proteins 0.000 description 1
- 108700012912 MYCN Proteins 0.000 description 1
- 101150022024 MYCN gene Proteins 0.000 description 1
- 108700026495 N-Myc Proto-Oncogene Proteins 0.000 description 1
- 102100030124 N-myc proto-oncogene protein Human genes 0.000 description 1
- 238000000636 Northern blotting Methods 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 239000013614 RNA sample Substances 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- 102000006382 Ribonucleases Human genes 0.000 description 1
- 108010083644 Ribonucleases Proteins 0.000 description 1
- 108091081021 Sense strand Proteins 0.000 description 1
- 108700025716 Tumor Suppressor Genes Proteins 0.000 description 1
- 102000044209 Tumor Suppressor Genes Human genes 0.000 description 1
- 108091023045 Untranslated Region Proteins 0.000 description 1
- 230000000692 anti-sense effect Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 108700021031 cdc Genes Proteins 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000007621 cluster analysis Methods 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000003831 deregulation Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000003828 downregulation Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 108091023663 let-7 stem-loop Proteins 0.000 description 1
- 108091063478 let-7-1 stem-loop Proteins 0.000 description 1
- 108091049777 let-7-2 stem-loop Proteins 0.000 description 1
- 238000003253 miRNA assay Methods 0.000 description 1
- 238000010208 microarray analysis Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000001823 molecular biology technique Methods 0.000 description 1
- 108091027963 non-coding RNA Proteins 0.000 description 1
- 102000042567 non-coding RNA Human genes 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 230000001124 posttranscriptional effect Effects 0.000 description 1
- 230000001323 posttranslational effect Effects 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000008844 regulatory mechanism Effects 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 230000002103 transcriptional effect Effects 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 230000001173 tumoral effect Effects 0.000 description 1
- 210000003741 urothelium Anatomy 0.000 description 1
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2007276191A JP2009100687A (ja) | 2007-10-24 | 2007-10-24 | ｍｉｃｒｏＲＮＡ発現プロファイリングに基づく膀胱癌の検出方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2007276191A JP2009100687A (ja) | 2007-10-24 | 2007-10-24 | ｍｉｃｒｏＲＮＡ発現プロファイリングに基づく膀胱癌の検出方法 |
Related Child Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012287862A Division JP5704576B2 (ja) | 2012-12-28 | 2012-12-28 | ｍｉｃｒｏＲＮＡ発現プロファイリングに基づく膀胱癌の検出方法 |
| JP2012287861A Division JP5704575B2 (ja) | 2012-12-28 | 2012-12-28 | ｍｉｃｒｏＲＮＡ発現プロファイリングに基づく膀胱癌の検出方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009100687A true JP2009100687A (ja) | 2009-05-14 |
| JP2009100687A5 JP2009100687A5 (enExample) | 2011-02-24 |
Family
ID=40703169
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007276191A Abandoned JP2009100687A (ja) | 2007-10-24 | 2007-10-24 | ｍｉｃｒｏＲＮＡ発現プロファイリングに基づく膀胱癌の検出方法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2009100687A (enExample) |
Cited By (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009143379A3 (en) * | 2008-05-21 | 2010-02-25 | Fred Hutchinson Cancer Research Center | Use of extracellular rna to measure disease |
| WO2011001906A1 (ja) | 2009-06-30 | 2011-01-06 | 富士レビオ株式会社 | 培養細胞の評価方法およびバイオマーカーのスクリーニング方法 |
| JP2011036242A (ja) * | 2009-07-16 | 2011-02-24 | Chiba Univ | ｍｉＲＮＡ発現プロファイリングに基づく尿路上皮癌の検出方法 |
| WO2012121178A1 (ja) * | 2011-03-04 | 2012-09-13 | 独立行政法人国立がん研究センター | 腫瘍血管形成阻害剤 |
| JP2013000067A (ja) * | 2011-06-17 | 2013-01-07 | Toray Ind Inc | 膀胱ガン診断用組成物及び方法 |
| CN102031254B (zh) * | 2009-09-27 | 2014-04-02 | 苏州吉玛基因股份有限公司 | 人miR-150反义核酸及其应用 |
| WO2015020122A1 (ja) * | 2013-08-08 | 2015-02-12 | 国立大学法人 大阪大学 | 尿路上皮癌の診断または治療剤 |
| JPWO2013038737A1 (ja) * | 2011-09-16 | 2015-03-23 | Ｌｓｉｐファンド運営合同会社 | 膀胱癌細胞の検出方法、膀胱癌細胞の検出方法に用いるプライマー及び膀胱癌マーカ |
| US9006201B2 (en) | 2010-07-08 | 2015-04-14 | Takeda Pharmaceutical Company Limited | Prophylactic or therapeutic agent for diabetes |
| CN105999269A (zh) * | 2016-05-05 | 2016-10-12 | 温州医科大学 | miR-411作为膀胱癌的靶标及其应用 |
| WO2019208671A1 (ja) * | 2018-04-25 | 2019-10-31 | 東レ株式会社 | 膀胱がんの検出のためのキット、デバイス及び方法 |
| CN120118996A (zh) * | 2025-03-06 | 2025-06-10 | 三二〇一医院 | 血浆miR-9和miR-106a作为胃癌患者腹膜癌变的诊断标志物及其相关产品 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005118806A2 (en) * | 2004-05-28 | 2005-12-15 | Ambion, Inc. | METHODS AND COMPOSITIONS INVOLVING MicroRNA |
| WO2006128245A1 (en) * | 2005-06-03 | 2006-12-07 | Southern Adelaide Health Service-Flinders Medical Centre | Targeting cells with altered microrna expression |
-
2007
- 2007-10-24 JP JP2007276191A patent/JP2009100687A/ja not_active Abandoned
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005118806A2 (en) * | 2004-05-28 | 2005-12-15 | Ambion, Inc. | METHODS AND COMPOSITIONS INVOLVING MicroRNA |
| JP2008500837A (ja) * | 2004-05-28 | 2008-01-17 | アンビオン インコーポレーティッド | マイクロｒｎａに関与する方法および組成物 |
| WO2006128245A1 (en) * | 2005-06-03 | 2006-12-07 | Southern Adelaide Health Service-Flinders Medical Centre | Targeting cells with altered microrna expression |
Non-Patent Citations (3)
| Title |
|---|
| JPN6012054374; Ａｎｎｕａｌ ｍｅｅｔｉｎｇ． Ｐｒｏｃｅｅｄｉｎｇｓ ｏｆ ｔｈｅ Ａｍｅｒｉｃａｎ Ａｓｓｏｃｉａｔｉｏｎ ｆｏｒ Ｃａｎｃｅｒ Ｒｅｓｅａｒｃｈ， ４８（Ａｐｒ． ２００７） ｐ．４２３（＃１７ * |
| JPN6012054375; Ｕｒｏｌ． Ｏｎｃｏｌ．， ２５［５］（Ｓｅｐ． ２００７） ｐ．３８７-３９２ * |
| JPN6012054376; Ｂｒｉｔｉｓｈ Ｊ． Ｃａｎｃｅｒ， ９５（２００６） ｐ．１４１５-１４１８ * |
Cited By (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009143379A3 (en) * | 2008-05-21 | 2010-02-25 | Fred Hutchinson Cancer Research Center | Use of extracellular rna to measure disease |
| EP2644706A2 (en) | 2009-06-30 | 2013-10-02 | Fujirebio Inc. | Method for evaluation of cultured cells, and method for screening of biomarker |
| WO2011001906A1 (ja) | 2009-06-30 | 2011-01-06 | 富士レビオ株式会社 | 培養細胞の評価方法およびバイオマーカーのスクリーニング方法 |
| JP2011036242A (ja) * | 2009-07-16 | 2011-02-24 | Chiba Univ | ｍｉＲＮＡ発現プロファイリングに基づく尿路上皮癌の検出方法 |
| CN102031254B (zh) * | 2009-09-27 | 2014-04-02 | 苏州吉玛基因股份有限公司 | 人miR-150反义核酸及其应用 |
| US9006201B2 (en) | 2010-07-08 | 2015-04-14 | Takeda Pharmaceutical Company Limited | Prophylactic or therapeutic agent for diabetes |
| WO2012121178A1 (ja) * | 2011-03-04 | 2012-09-13 | 独立行政法人国立がん研究センター | 腫瘍血管形成阻害剤 |
| JP2013000067A (ja) * | 2011-06-17 | 2013-01-07 | Toray Ind Inc | 膀胱ガン診断用組成物及び方法 |
| JPWO2013038737A1 (ja) * | 2011-09-16 | 2015-03-23 | Ｌｓｉｐファンド運営合同会社 | 膀胱癌細胞の検出方法、膀胱癌細胞の検出方法に用いるプライマー及び膀胱癌マーカ |
| EP2757154A4 (en) * | 2011-09-16 | 2015-10-14 | Lsip Llc | METHOD FOR DETECTING BLOOD TUMOR CELLS, PRIMER FOR USE IN THIS METHOD FOR DETECTING BLOOD TUMOR CELLS AND BLADDER CANCER MARKERS |
| WO2015020122A1 (ja) * | 2013-08-08 | 2015-02-12 | 国立大学法人 大阪大学 | 尿路上皮癌の診断または治療剤 |
| JPWO2015020122A1 (ja) * | 2013-08-08 | 2017-03-02 | 国立大学法人大阪大学 | 尿路上皮癌の診断または治療剤 |
| CN105999269A (zh) * | 2016-05-05 | 2016-10-12 | 温州医科大学 | miR-411作为膀胱癌的靶标及其应用 |
| WO2019208671A1 (ja) * | 2018-04-25 | 2019-10-31 | 東レ株式会社 | 膀胱がんの検出のためのキット、デバイス及び方法 |
| CN120118996A (zh) * | 2025-03-06 | 2025-06-10 | 三二〇一医院 | 血浆miR-9和miR-106a作为胃癌患者腹膜癌变的诊断标志物及其相关产品 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Wu et al. | Expression profile of mammalian microRNAs in endometrioid adenocarcinoma | |
| JP2009100687A (ja) | ｍｉｃｒｏＲＮＡ発現プロファイリングに基づく膀胱癌の検出方法 | |
| Deb et al. | miRNAs and ovarian cancer: An overview | |
| Porkka et al. | MicroRNA expression profiling in prostate cancer | |
| Muralidhar et al. | Global microRNA profiles in cervical squamous cell carcinoma depend on Drosha expression levels | |
| Veerla et al. | MiRNA expression in urothelial carcinomas: important roles of miR‐10a, miR‐222, miR‐125b, miR‐7 and miR‐452 for tumor stage and metastasis, and frequent homozygous losses of miR‐31 | |
| Mattie et al. | Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies | |
| Resnick et al. | The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform | |
| Ramdas et al. | miRNA expression profiles in head and neck squamous cell carcinoma and adjacent normal tissue | |
| Li et al. | miR-128 and its target genes in tumorigenesis and metastasis | |
| White et al. | MicroRNAs and their potential for translation in prostate cancer | |
| Guancial et al. | The evolving understanding of microRNA in bladder cancer | |
| Tatarano et al. | miR-218 on the genomic loss region of chromosome 4p15. 31 functions as a tumor suppressor in bladder cancer | |
| Schaefer et al. | MicroRNAs and cancer: current state and future perspectives in urologic oncology | |
| EP2391738B1 (en) | Methods of detecting sepsis | |
| Mezzanzanica et al. | Role of microRNAs in ovarian cancer pathogenesis and potential clinical implications | |
| George et al. | MicroRNAs: Potential biomarkers in cancer | |
| EP2281903B1 (en) | METHOD FOR EVALUATION OF CANCER BY USING miRNA CANCER MARKER | |
| Nugent et al. | MicroRNAs in colorectal cancer: function, dysregulation and potential as novel biomarkers | |
| CN101878314A (zh) | 用于监控结肠直肠癌的方法 | |
| WO2009012263A2 (en) | Tissue-specific micrornas and compositions and uses thereof | |
| Leonardi et al. | microRNAs and thyroid cancer: Biological and clinical significance | |
| WO2008125883A1 (en) | Cancer markers for prognosis and screening of anti-cancer agents | |
| Mutalib et al. | MicroRNAs and lymph node metastasis in papillary thyroid cancers | |
| GB2536374A (en) | Biomarkers useful for detection of types, grades and stages of human breast cancer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20101021 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20101021 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20101201 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20121106 |
|
| A762 | Written abandonment of application |
Free format text: JAPANESE INTERMEDIATE CODE: A762 Effective date: 20130121 |